tadalafil has been researched along with Multiple Sclerosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chabot, F; Chaouat, A; Gomez, E; Guillaumot, A; Petitpain, N; Ribeiro Baptista, B; Valentin, S; Yelehé-Okouma, M | 1 |
| Aversa, A; Cortese, A; Francomano, D; Ilacqua, A; Inghilleri, M; Lenzi, A; Tartaglia, G | 1 |
| Del Popolo, G; Lombardi, G; Macchiarella, A | 1 |
| Pan, W; Wu, J; Zhang, HL | 1 |
| Celso, M; Del Popolo, G; Lombardi, G; Mencarini, M; Nelli, F | 1 |
1 review(s) available for tadalafil and Multiple Sclerosis
| Article | Year |
|---|---|
Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature.
Topics: Carbolines; Central Nervous System Diseases; Clinical Trials as Topic; Humans; Imidazoles; Impotence, Vasculogenic; Male; Multiple Sclerosis; Parkinson Disease; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Spinal Dysraphism; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride | 2012 |
1 trial(s) available for tadalafil and Multiple Sclerosis
| Article | Year |
|---|---|
Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis.
Topics: Adult; Carbolines; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erectile Dysfunction; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Phosphodiesterase 5 Inhibitors; Quality of Life; Tadalafil; Treatment Outcome | 2010 |
3 other study(ies) available for tadalafil and Multiple Sclerosis
| Article | Year |
|---|---|
Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine.
Topics: 4-Aminopyridine; Antihypertensive Agents; Dyspnea; Female; Humans; Hypertension, Pulmonary; Middle Aged; Multiple Sclerosis; Phenylpropionates; Potassium Channel Blockers; Pyridazines; Tadalafil | 2019 |
Effects of daily tadalafil on lower urinary tract symptoms in young men with multiple sclerosis and erectile dysfunction: a pilot study.
Topics: Adult; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Multiple Sclerosis; Phosphodiesterase 5 Inhibitors; Pilot Projects; Prognosis; Prospective Studies; Single-Blind Method; Tadalafil | 2017 |
Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis.
Topics: Carbolines; Humans; Impotence, Vasculogenic; Male; Multiple Sclerosis; Phosphodiesterase 5 Inhibitors; Risk Factors; Tadalafil | 2011 |